novointegrated.com (NVOS): Growth-Adjusted P/E Ratio
Novo Integrated Sciences is currently restructuring its obligations and seeking ways to stabilize liquidity through micro-acquisitions. The business model relies on linking telemedicine with local centers amid elastic demand. Treatment efficiency is ensured by the centralized supply of consumables to branches. The PEG growth stock indicator demonstrates the asset's fundamental potential, and its value is fixed at 0.00.
Novo Integrated Sciences, Inc. (NVOS) - metric breakdowns and financial figures
- current quotes and average value forecast:
- stock exchange capitalization data:
- business book valuation details:
- business debt structure and liquidity details:
Debt to Capital Novo Integrated Sciences|NVOS - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Novo Integrated Sciences Inc|NVOS - Company Debts|Debts to Book Value Novo Integrated Sciences, Inc.|NVOS - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Novo Integrated Sciences|Interim Coverage Ratio novointegrated.com
- earnings and market ratios statistics:
NVOS - Company Net Income|Net Profit Forecast Novo Integrated Sciences|NVOS - Price to Earnings Ratio|Market Cap to Future Earnings Ratio Novo Integrated Sciences|NVOS - PEG Multiple|Company Value to EBITDA Novo Integrated Sciences Corp|NVOS - Operating profit EBITDA|Net earnings per share for the trailing year Novo Integrated Sciences|NVOS - Earnings per share for the last twelve months|Year-over-year earnings per one share growth for the last 12 months novointegrated.com|NVOS - Earnings growth in current year|Earnings growth forecast for next year Novo Integrated Sciences
- total revenue and sales volume data:
Fundamental company analysis:NVOS - Novo Integrated Sciences
The PEG ratio compares an asset's market value to its earnings growth, where a value below one signals a fundamental undervaluation of the business's growth rate. By analyzing the weighted price-to-earnings-to-growth ratio, an investor can confirm the resilience of Novo Integrated Sciences (NVOS), whose defensive barriers in the form of strict government licensing and Medicare compliance provide a long-term competitive advantage.
Who Novo Integrated Sciences competes with
HCA Holdings - Growth-Adjusted P/E Ratio|Tenet - Price/Earnings to Growth Multiple|Company Value to Earnings Growth Ratio FMS (Fresenius Medical Care)|SOLV: Price/Earnings to Growth Multiple|Price to Earnings Adjusted for Growth Rate Encompass Health Corp|Universal Health Services (UHS) - Price/Earnings to Growth Ratio|DaVita Inc. (DVA) - PEG Multiple|RDNT (RadNet Management) - PEG Multiple|Option Care Health, Inc. - Market Cap to Earnings and Growth Ratio|Price/Earnings to Growth Ratio Surgery Partners (SGRY)|PINC - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio nationalvision.com EYE|Price to Net Income Growth Ratio Progyny, Inc.|ARDT - Price/Earnings to Growth Ratio|Select Medical Holdings - Company Value to Earnings Growth Ratio|Apollo Medical Holdings (ASTH) - Price/Earnings to Growth Ratio|MD - Growth-Adjusted Market Cap to Net Income|USPH (usph.com) - PEG Multiple|Growth-Adjusted P/E Ratio PNTG (The Pennant Group Corp)|PEG Multiple ORGO|NUTX - Price to Earnings Adjusted for Growth Rate|aunainvestors.com - Price/Earnings to Growth Multiple|PEG Multiple SBC Medical Group Holdings Inc. SBC|Evolus Corp - PEG Multiple|Growth-Adjusted Payback Ratio CYH (Community Health Systems Inc)|SKIN (Beauty Health) - Price/Earnings to Growth Multiple|MDWD (MediWound Ltd.) - Price/Earnings to Growth Ratio|BTMD (biote Corp) - PEG Multiple|Price to Earnings Adjusted for Growth Rate The Joint Corp JYNT|PEG Multiple DCGO|Price/Earnings to Growth Multiple p3hp.org PIII|Gain Therapeutics, Inc. - Price/Earnings to Growth Multiple|EUDA: Growth-Adjusted P/E Ratio|baselmedical.com - PEG Multiple|Price to Earnings Adjusted for Growth Rate collplant.com|Cuprina Holdings Limited (CUPR) - Price/Earnings to Growth Ratio|CCM - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Ratio American Shared Hospital Services Inc|Growth-Adjusted P/E Ratio MRM (MEDIROM Healthcare Group)|Price/Earnings to Growth Ratio Avalon GloboCare Corp. (ALBT)|Price/Earnings to Growth Multiple DIH Holding US Inc. DHAI|Price/Earnings to Growth Ratio carmellcosmetics.com XAGE|NIVF - Price/Earnings to Growth Multiple|ATIP: Price/Earnings to Growth Multiple|CMAX - PEG Multiple|KDLY: PEG Multiple|Price to Earnings Adjusted for Growth Rate ModivCare (MODV)|Price/Earnings to Growth Ratio SunLink Health Systems, Inc.|PEG Multiple IMAC Holdings, Inc.
